Tag: NeoPhore

spot_imgspot_img

NeoPhore: Closes £6M Extension to Series B; Round to £21.5M

NeoPhore Closes £6M Extension to Series B; Round to £21.5MNeoPhore, a Cambridge, UK-based small molecule neoantigen immuno-oncology company, raised £6M in an extension...